PMO Interview with the Innovator Series: Volume 5

Michael Pellini, MD
Video Categories: PMO Interview with the Innovator Series

Michael Pellini, President and Chief Executive Officer of Foundation Medicine, offers a definition of personalized medicine in this new video series from Personalized Medicine in Oncology.

October 7, 2016

Common Issues in Treating Patients with HR+/ HER2-Negative Metastatic Breast Cancer

Dr Hope Rugo discusses some of the choices and challenges she’s faced with in treating patients with HR+/ HER2-negative metastatic breast cancer with the goal of helping patients live as long as possible and with the best quality of life.

March 31, 2015

Precision Medicine for CLL

Dr. Jennifer R. Brown deliberates on the state of personalized medicine in relation to CLL. She explains that the targeted drugs currently used for CLL actually work for most patients, rather than just a subgroup. Also, CLL therapies are now generally in pill form and well tolerated with few side [ Read More ]